Prevalent platelet dysfunction in patients with aortic valve disease

Journal of Heart Valve Disease

Volumn 17, Issue 5, 2008, Pages 542-547

  Prohaska, Wolfgang ^a   Zittermann, Armin ^a   Lüth, Jan U ^a   Inoue, Kazuo ^a   Köster Eiserfunke, Wilhelm ^a   Bailer, Detlev ^a   Körfer, Reiner ^a   Kleesiek, Knut ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; FIBRINOGEN RECEPTOR; UNCLASSIFIED DRUG; VON WILLEBRAND ANTIGEN; VON WILLEBRAND FACTOR RECEPTOR;

AGED; AORTA VALVE STENOSIS; ARTICLE; BLOOD; BLOOD CLOTTING PARAMETERS; COHORT ANALYSIS; CORONARY ARTERY BYPASS GRAFT; FEMALE; HEART VALVE PROSTHESIS; HUMAN; MALE; METABOLISM; MIDDLE AGED; PHYSIOLOGY; RETROSPECTIVE STUDY; THROMBOCYTE ACTIVATION; THROMBOCYTE DISORDER; VON WILLEBRAND DISEASE;

AGED; ANTIGENS; AORTIC VALVE STENOSIS; BLOOD PLATELET DISORDERS; COHORT STUDIES; CORONARY ARTERY BYPASS; FEMALE; HEART VALVE PROSTHESIS; HUMANS; MALE; MIDDLE AGED; PLATELET ACTIVATION; PLATELET FUNCTION TESTS; PLATELET MEMBRANE GLYCOPROTEINS; RETROSPECTIVE STUDIES; VON WILLEBRAND DISEASE;

EID: 58749090035     PISSN: 09668519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Petty GW, Khandheria BK, Whisnant JP, et al. Predictors of cerebrovascular events and death among patients with valvular heart disease. A population-based study. Stroke 2000; 31:2628-2635
2. Adams GF, Merrett JD, Hutchinson WM, et al. Cerebral embolism and mitral stenosis: Survival with and without anticoagulants. J Neurol Neurosurg Psychiatry 1974; 37:378-383
3. Vincentelli A, Susen S, Le Tourneau T, et al. Acquired von Willebrand syndrome in aortic stenosis. N Engl J Med 2003; 349:343-349
4. Francis JL. Platelet dysfunction detected at high shear in patients with heart valve disease. Platelets 2000; 11:133-136
5. Bock M, De Haan J, Beck KH, et al. Standardization of the PFA-100(R) platelet function test in mmol/1 buffered citrate: Effect of gender, smoking, and oral contraceptives. Br J Haematol 1999; 106:898-904
6. Sestito A, Sciahbasi A, Landolfi R, et al. A simple assay for platelet-mediated haemostasis in flowing whole blood (PFA-100): Reproducibility and effects of sex and age. Cardiologia 1999; 44:661-665
7. Hagberg IA, Roald HE, Lyberg T. Platelet activation in flowing blood passing growing arterial thrombi. Arterioscler Thromb Vasc Biol 1997; 17:1331-1336
8. Sakariassen KS, Holme PA, Orvim U, et al. Shearinduced platelet activation and platelet microparticle formation in native human blood. Thromb Res 1998; 92(6 Suppl.2):S33-S41
9. Conard J, Horellou MH, Baillet M, et al. Plasma beta-thromboglobulin in patients with valvular heart disease with or without valve replacement: Relationship with thromboembolic accidents. Eur Heart J 1984; 5(Suppl. D):13-18
10. Kunishima S, Hattori M, Kobayashi S, et al. Activation and destruction of platelets in patients with rheumatic heart disease. Eur Heart J 1994; 15:335-338
11. Holme PA, Orvim U, Hamers MJ, et al. Shearinduced platelet activation and platelet microparticle formation at blood flow conditions as in arteries with a severe stenosis. Arterioscler Thromb Vase Biol 1997; 17:646-653
12. Zhang J, Bergeron AL, Yu Q, et al. Duration of exposure to high fluid shear stress is critical in shearinduced platelet activation-aggregation. Thromb Haemost 2003; 90:672-678
13. Riddle JM, Magilligan DJ, Jr., Stein PD. Surface topography of stenotic valves by scanning electron microscopy. Circulation 1980; 61:496-502
14. Rubboli A, Verheugt FW. Antithrombotic treatment for patients on oral anticoagulation undergoing coronary stenting: A review of the available evidence and practical suggestions for the clinician. Int J Cardiol 2008; 123:234-239
15. Levi M, de Jonge E, van der Poll T. Plasma and plasma components in the management of disseminated intravascular coagulation. Best Pract Res Clin Haematol 2006; 19:127-142
16. Katoh K, Sone M, Kuroda T, et al. A case of cerebral infarction caused by disseminated intravascular coagulation during hepatic arterial infusion chemotherapy. Gan To Kagaku Ryoho 2005; 32:1051-1053 (in Japanese)
17. Mukundan S, Zeigler ZR. Direct antithrombin agents ameliorate disseminated intravascular coagulation in suspected heparin-induced thrombocytopenia thrombosis syndrome. Clin Appl Thromb Hemost 2002; 8:287-289
18. Diehl P, Nagy F, Sossong V, et al. Increased levels of circulating microparticles in patients with severe aortic valve stenosis. Thromb Haemost 2008; 99: 711-719
19. Grau AJ, Weimar C, Buggie F, et al. Risk factors, outcome, and treatment in subtypes of ischemic stroke: The German Stroke Data Bank. Stroke 2001; 32:2559-2566
20. Taha TH, Durrant S, Crick J, et al. Haemostatic studies in patients with infective endocarditis: A report on nine consecutive cases with evidence of coagulopathy. Heart Vessels 1991; 6:102-106
21. Butler J, Rocker GM, O'Brien JR, et al. Platelet responses to cardiopulmonary bypass. Assessment by shear stress activation technique. J Cardiovasc Surg 1992; 33:33-37
22. Tanaka R, Yamane Y. Platelet aggregation in dogs with mitral valve regurgitation. Am J Vet Res 2000; 61:1248-1251
23. Kunishima S, Hattori M, Kobayashi S, et al. Activation and destruction of platelets in patients with rheumatic heart disease. Eur Heart J 1994; 15:335-338